Cargando…

Compassionate use and emergency use authorization for unapproved drugs : FDA policies and background /

Detalles Bibliográficos
Clasificación:	Libro Electrónico
Otros Autores:	Burke, Tonya (Editor )
Formato:	Electrónico eBook
Idioma:	Inglés
Publicado:	New York : Nova Publishers, [2016]
Colección:	Drug transit and distribution, interception and control.
Temas:	United States. > Food and Drug Administration. United States. > Food and Drug Administration Drug approval > United States. Drugs > United States > Administration. Drug control > United States. Médicaments > Autorisation de mise sur le marché > États-Unis. Médicaments > États-Unis > Administration. Lutte antidrogue > États-Unis. BUSINESS & ECONOMICS / Infrastructure SOCIAL SCIENCE / General Drug approval Drug control Drugs > Administration United States
Acceso en línea:	Texto completo

Ejemplares similares

Development and approval of combination products : a regulatory perspective /
Publicado: (2008)

Development of FDA-regulated medical products : a translational approach /
por: Whitmore, Elaine
Publicado: (2012)

Development of FDA-regulated medical products : a translational approach /
por: Whitmore, Elaine
Publicado: (2012)

The future of drug safety : promoting and protecting the health of the public /
Publicado: (2007)

To America's health : a proposal to reform the Food and Drug Administration /
por: Miller, Henry I.
Publicado: (2000)

Making better drugs for children with cancer /
Publicado: (2005)

Making better drugs for children with cancer /
Publicado: (2005)

Building a national framework for the establishment of regulatory science for drug development : workshop summary /
Publicado: (2011)

The textbook of pharmaceutical medicine /
Publicado: (2013)

Development and approval of combination products a regulatory perspective /
Publicado: (2008)

Reputation and power : organizational image and pharmaceutical regulation at the FDA /
por: Carpenter, Daniel P., 1967-
Publicado: (2010)

Ethical and scientific issues in studying the safety of approved drugs /
Publicado: (2012)

Challenges for the FDA : the Future of Drug Safety : Workshop Summary /
Publicado: (2007)

FDA's drug review process and the package label : strategies for writing successful FDA submissions /
por: Brody, Tom
Publicado: (2017)

Reputation and power : organizational image and pharmaceutical regulation at the FDA /
por: Carpenter, Daniel P., 1967-
Publicado: (2010)

Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop /
Publicado: (2010)

Considerations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches : summary of a workshop /
Publicado: (2010)

Public health effectiveness of the FDA 510(k) clearance process : measuring postmarket performance and other select topics : workshop report /
Publicado: (2011)

The risks of prescription drugs /
Publicado: (2010)

Public health effectiveness of the FDA 510(k) clearance process : measuring postmarket performance and other select topics : workshop report /
Publicado: (2011)

A risk-characterization framework for decision-making at the Food and Drug Administration /
Publicado: (2011)

A risk-characterization framework for decision-making at the Food and Drug Administration /
Publicado: (2011)

Perspectives on Drug Use in the United States.
por: Segal, Bernard
Publicado: (2014)

Reputation and Power : Organizational Image and Pharmaceutical Regulation at the FDA /
por: Carpenter, Daniel P., 1967-
Publicado: (2010)

Food and Drug Administration Safety and Innovation Act : provisions and analyses of user fees /
Publicado: (2014)

Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary /
por: Boname, Morgan L., et al.
Publicado: (2016)

Drug compounding : background, issues and FDA oversight /
Publicado: (2014)

International regulatory harmonization amid globalization of drug development : workshop summary /
por: Weisfeld, Victoria D., et al.
Publicado: (2013)

Pharmaceutical lifecycle management : making the most of each and every brand /
por: Ellery, Tony
Publicado: (2012)

Lies, damned lies, and drug war statistics : a critical analysis of claims made by the Office of National Drug Control Policy /
por: Robinson, Matthew, 1970-
Publicado: (2014)

Drugs and Justice : Seeking a Consistent, Coherent, Comprehensive View.
por: Battin, M. Pabst
Publicado: (2007)

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary /
Publicado: (2009)

Safe and effective medicines for children : studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
Publicado: (2012)

The Risks of Prescription Drugs.
por: Light, Don
Publicado: (2010)

Drugs : America's Holy War.
por: Benavie, Arthur
Publicado: (2012)

Drugs and thugs : the history and future of America's war on drugs /
por: Crandall, Russell, 1971-
Publicado: (2020)

Drugs and thugs : the history and future of America's war on drugs /
por: Crandall, Russell, 1971-
Publicado: (2020)

Drugs and justice : seeking a consistent, coherent, comprehensive view /
por: Battin, M. Pabst
Publicado: (2008)

Personalized medicine and the FDA's emerging role /
Publicado: (2014)

Early drug development : strategies and routes to first-in-human trials /
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_marhagol3psvp1912rqumh6oet